Lv3
330 积分 2025-02-03 加入
Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma
8天前
已完结
Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy
2个月前
已完结
DREAMM-7: A Phase III Study of the Efficacy and Safety of Belantamab Mafodotin (Belamaf) with Bortezomib, and Dexamethasone (B-Vd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
8个月前
已关闭
皖公网安备34019202002308
